| Mankind Pharma Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 543904 |
NSE Symbol : MANKIND |
P/E(TTM) : 51.96 |
|
ISIN Demat : INE634S01028 |
Div & Yield% : - |
EPS(TTM) : 46.79 |
|
Book Value(₹) : 240.21 |
Market Cap(₹Cr) : 97,396.59 |
Face Value(₹) : 1.00 |
| Particulars | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Gross Sales | 2,403.26 | 1,996.55 | 2,358.57 | 2,453.35 | 2,092.28 | 1,872.12 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 2,403.26 | 1,996.55 | 2,358.57 | 2,453.35 | 2,092.28 | 1,872.12 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 124.07 | 107.43 | 67.23 | 58.12 | 86.94 | 42.46 |
| Total Income | 2,527.33 | 2,103.98 | 2,425.80 | 2,511.46 | 2,179.22 | 1,914.58 |
| Total Expenditure | 1,831.06 | 1,481.38 | 1,755.46 | 1,818.15 | 1,594.32 | 1,490.96 |
| PBIDT | 696.27 | 622.60 | 670.34 | 693.31 | 584.90 | 423.62 |
| Interest | 6.26 | 4.03 | 4.26 | 4.31 | 1.97 | 0.88 |
| PBDT | 690.01 | 618.57 | 666.08 | 689.00 | 582.93 | 422.73 |
| Depreciation | 83.40 | 82.25 | 89.73 | 77.04 | 68.51 | 67.30 |
| Tax | 108.34 | 104.53 | 74.41 | 122.25 | 91.36 | 80.89 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -15.22 | -22.38 | 14.87 | 16.82 | 13.78 | -6.45 |
| Reported Profit After Tax | 513.49 | 454.17 | 487.07 | 472.88 | 409.28 | 280.99 |
| Extra-ordinary Items | 29.24 | 23.58 | 0.00 | 0.00 | 29.50 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 484.25 | 430.59 | 487.07 | 472.88 | 379.78 | 280.99 |
| EPS (Unit Curr.) | 12.82 | 11.34 | 12.16 | 11.80 | 10.22 | 7.01 |
| EPS (Adj) (Unit Curr.) | 12.82 | 11.34 | 12.16 | 11.80 | 10.22 | 7.01 |
| Calculated EPS (Unit Curr.) | 12.82 | 11.34 | 12.16 | 11.80 | 10.22 | 7.01 |
| Calculated EPS (Adj) (Unit Curr.) | 12.82 | 11.34 | 12.16 | 11.80 | 10.22 | 7.01 |
| Calculated EPS (Ann.) (Unit Curr.) | 51.27 | 45.35 | 48.64 | 47.22 | 40.87 | 28.06 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 51.27 | 45.35 | 48.64 | 47.22 | 40.87 | 28.06 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 40.06 | 40.06 | 40.06 | 40.06 | 40.06 | 40.06 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 28.97 | 31.18 | 28.42 | 28.26 | 27.96 | 22.63 |
| PBDTM(%) | 28.71 | 30.98 | 28.24 | 28.08 | 27.86 | 22.58 |
| PATM(%) | 21.37 | 22.75 | 20.65 | 19.27 | 19.56 | 15.01 |